All News

Sabrina K. Griggs, RPh, ACN, and her staff take pride in providing personalized care to patients in Kerrville, Texas.

Recognizing early signs and seeking medical care is essential for effective treatment and preventing long-term health complications.

The acceptance will lead to vaccines that provide better protection against the KP.2 strain of SARS-CoV-2.

Drawing on years of experience, Rina Shah explains how sustainable care models are essential for a thriving pharmaceutical industry.

The FDA assigned the combination a Prescription Drug User Fee Act goal date of April 21, 2025.

Individuals with chronic conditions like asthma, diabetes, and chronic obstructive pulmonary disease face an increased risk of developing RSV.

Communities that are impacted by increased wildfires can experience increased health risks, particularly among those who have asthma or chronic obstructive pulmonary disease.

Palliative care is crucial for safe and effective medication management to relieve symptoms and improve quality of life.

In an interview with Pharmacy Times, Jon Easter discusses the need for pharmacy to align as a profession to achieve policy and research goals.

Tune into this episode of “Public Health Matters” to learn about how Healthcare Advocate Summit, created by advocates for advocates, is involved in the discussion on improving access to health care.

President of NACDS, Steve Anderson, discusses how the events at Total Store Expo reflect on the association's goals of innovation and a focus on public policy.

Pharmacists are key resource points to navigate the nuances of keto diets and chronic health management.

When a community loses a pharmacy, it loses a trusted health care provider. Understanding the root causes of these closures—and what we can do about it—can drive change.

Biosimilar etanercept (Sunshine Guojian Pharmaceutical) showed similar therapeutic outcomes compared with etanercept (Enbrel; Amgen) specific to rheumatoid arthritis.

Sara Roszak recounts the Annual NACDS Foundation Dinner and their role in implementing research at the clinical level.

The use of intravenous immunoglobulin led to positive protective effects on osteoporosis.

Brandon Newman highlights the need for balanced regulation, transparency, and real-time data access to ensure fair competition and optimal outcomes for pharmacy benefit mangers.

The bispecific CAR T-cell therapy for treatment of multiple sclerosis is the first to target both CD19 and CD20.

The money could be used for prevention and treatment services, health care practitioner training, or other ways to stem the epidemic.

The decision by the Supreme Court has the potential to upend the power of regulatory agencies to shape the health care landscape of the country.

These pharmacies bring high-touch specialty pharmacies into local communities for patients with more complex needs.

Joseph Saseen offers valuable insights into the implications of the added performance and quality measures for patients and health care providers.

The breakthrough therapy designation was granted based on ongoing data from the ARTEMIS-001 phase 1 open-label, multi-center trial.

SMOs offer a range of services, including site selection, patient recruitment, data management, regulatory compliance, and quality assurance.

Propofol has a history of chronic shortage due to supply chain constraints.

Jasmine Perry discusses the More Than a Script program in an interview with Pharmacy Times.

Brandon Newman discusses the significant influence of the "big 3" pharmacy benefit managers and the key legislative and regulatory efforts around transparency.